Webinar Summary: Unlock Microbiome-Host Interaction with Metabolomics
In recent years, microbiome research has dramatically reshaped our understanding of how microbes impact on a multitude of (patho-)physiological processes in the host. However, causal links between the microbiota and diseases are still lacking to a large extent. Metabolomics allows the investigation of microbial metabolic activities, and is thus an ideal "omics" technology for assessing functional host-microbiota interaction.
In the first part of the webinar, recent advancements of metabolomics in microbiota research and key metabolic pathways will be highlighted.
The second part of the webinar will focus on the introduction of the MxP® Quant 500 kit, the worldwide first standardized solution for the targeted quantification up to 630 endogenous and microbiota-derived metabolites and lipids generating accurate and reproducible results.
Key Learning objectives:
Role of functional host-microbiota interactions in health and disease
Tools for the analysis of functional microbiomics
Key benefits and analytical performance of the MxP® Quant 500 kit
Biological relevance of the metabolic pathways covered by the MxP® Quant 500 kit
Advantages of standardized and targeted metabolomics
Barbara Wolf, Ph.D. Knowledge Manager, Scientific Marketing & Biochemist,
BIOCRATES Life Sciences AG
Therese Koal, Ph.D Head of Research & Development, BIOCRATES Life Sciences AG.
Technology Networks Limited
Woodview | Bull Lane Industrial Estate | Sudbury | C010 0FD | UK